Cart
sales@molnova.com
Home - Products - Angiogenesis - Adrenergic Receptor - LUN42518 HCl 47142-51-8(free base)

LUN42518 HCl 47142-51-8(free base)

CAS No.

LUN42518 HCl 47142-51-8(free base) ( —— )

Catalog No. M22766 CAS No.

LUN42518 HClis an analogue of phentolamine.Phentolamine is a nonselective alpha-adrenergic antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 357 In Stock
10MG 597 In Stock
25MG 882 In Stock
50MG 1350 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    LUN42518 HCl 47142-51-8(free base)
  • Note
    Research use only, not for human use.
  • Brief Description
    LUN42518 HClis an analogue of phentolamine.Phentolamine is a nonselective alpha-adrenergic antagonist.
  • Description
    LUN42518 HClis an analogue of phentolamine.Phentolamine is a nonselective alpha-adrenergic antagonist.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    Adrenergic Receptor
  • Recptor
    α-adrenergic receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    --
  • Formula Weight
    317.81
  • Molecular Formula
    C17H20ClN3O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.Cc1ccc(cc1)N(CC1=NCCN1)c1ccc(O)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.J.A. Parihar, et al. Alkylation of diphenylamines with chloroacetonitrile: a new entry to phentolamine analogues. Journal of Chemical Research (2004), (3), 220-222.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Rec 15/2615 dihydroc...

    Rec 15/2615 dihydrochloride is an antagonist of α1B-adrenergic receptor.

  • Dabuzalgron

    Dabuzalgron is an orally active selective alpha-1A adrenergic receptor agonist used to treat urinary incontinence. Dabuzaron prevents cardiotoxicity caused by doxorubicin by maintaining mitochondrial function.Dabuzaron treatment increased ERK phosphorylation in a dose-dependent manner with an EC50 of 4.8 μM.

  • MK-4618

    A potent and selective full β3 adrenergic receptor agonist with EC50 of 1.1 nM; displays no activity for β1 and β2 receptors (EC50>20 uM).

Sign In Join Free